van Breemen RB[Author] - Search Results

Year	Number of Results
1984	1
1985	1
1986	3
1987	1
1988	1
1989	1
1990	1
1991	3
1992	1
1993	1
1995	1
1996	1
1997	4
1998	6
1999	7
2000	7
2001	17
2002	11
2003	20
2004	13
2005	20
2006	11
2007	13
2008	15
2009	10
2010	15
2011	16
2012	18
2013	19
2014	14
2015	9
2016	15
2017	11
2018	10
2019	8
2020	11
2021	12
2022	6

1

Caco-2 cell permeability assays to measure drug absorption.

van Breemen RB, Li Y. van Breemen RB, et al. Expert Opin Drug Metab Toxicol. 2005 Aug;1(2):175-85. doi: 10.1517/17425255.1.2.175. Expert Opin Drug Metab Toxicol. 2005. PMID: 16922635 Review.

2

Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.

van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG. van Breemen RB, et al. J Nat Prod. 2022 Jan 28;85(1):176-184. doi: 10.1021/acs.jnatprod.1c00946. Epub 2022 Jan 10. J Nat Prod. 2022. PMID: 35007072 Free PMC article.

3

The Multiple Biological Targets of Hops and Bioactive Compounds.

Bolton JL, Dunlap TL, Hajirahimkhan A, Mbachu O, Chen SN, Chadwick L, Nikolic D, van Breemen RB, Pauli GF, Dietz BM. Bolton JL, et al. Among authors: van breemen rb. Chem Res Toxicol. 2019 Feb 18;32(2):222-233. doi: 10.1021/acs.chemrestox.8b00345. Epub 2019 Jan 22. Chem Res Toxicol. 2019. PMID: 30608650 Free PMC article. Review.

4

Catherine Fenselau: A distinguished career dedicated to biomedical mass spectrometry.

van Breemen RB, Hathout Y, Fabris D. van Breemen RB, et al. J Mass Spectrom. 2020 Feb;55(2):e4500. doi: 10.1002/jms.4500. J Mass Spectrom. 2020. PMID: 32073193 No abstract available.

5

Drug discovery from natural products using affinity selection-mass spectrometry.

Muchiri RN, van Breemen RB. Muchiri RN, et al. Among authors: van breemen rb. Drug Discov Today Technol. 2021 Dec;40:59-63. doi: 10.1016/j.ddtec.2021.10.005. Epub 2021 Oct 21. Drug Discov Today Technol. 2021. PMID: 34916024 Review.

6

Multitargeted therapy of cancer by lycopene.

van Breemen RB, Pajkovic N. van Breemen RB, et al. Cancer Lett. 2008 Oct 8;269(2):339-51. doi: 10.1016/j.canlet.2008.05.016. Epub 2008 Jun 27. Cancer Lett. 2008. PMID: 18585855 Free PMC article. Review.

7

Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements.

Sprouse AA, van Breemen RB. Sprouse AA, et al. Among authors: van breemen rb. Drug Metab Dispos. 2016 Feb;44(2):162-71. doi: 10.1124/dmd.115.066902. Epub 2015 Oct 5. Drug Metab Dispos. 2016. PMID: 26438626 Free PMC article. Review.

8

Nature's palette: the search for natural blue colorants.

Newsome AG, Culver CA, van Breemen RB. Newsome AG, et al. Among authors: van breemen rb. J Agric Food Chem. 2014 Jul 16;62(28):6498-511. doi: 10.1021/jf501419q. Epub 2014 Jul 8. J Agric Food Chem. 2014. PMID: 24930897 Review.

9

Applications of pulsed ultrafiltration-mass spectrometry.

Johnson BM, Nikolic D, van Breemen RB. Johnson BM, et al. Among authors: van breemen rb. Mass Spectrom Rev. 2002 Mar-Apr;21(2):76-86. doi: 10.1002/mas.10020. Mass Spectrom Rev. 2002. PMID: 12373745 Review.

10

Finding the bad actor: Challenges in identifying toxic constituents in botanical dietary supplements.

Roberts GK, Gardner D, Foster PM, Howard PC, Lui E, Walker L, van Breemen RB, Auerbach SS, Rider C. Roberts GK, et al. Among authors: van breemen rb. Food Chem Toxicol. 2019 Feb;124:431-438. doi: 10.1016/j.fct.2018.12.026. Epub 2018 Dec 21. Food Chem Toxicol. 2019. PMID: 30582954 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results